Overview
Clinical Benefits
- Cellular energy production
- DNA repair support
- Anti-aging at cellular level
- Improved mental clarity
- Addiction recovery support
Administration
Subcutaneous injection, intramuscular, or IV infusion
Drug class: coenzyme
Clinical Dosing
Typical dosage
50-250mg (subcutaneous) or 250-750mg (IV)
Starting dose
50mg
Cadence
2-3x weekly (subcutaneous)
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 50mg subcutaneous 2-3x weekly |
| Weeks 3-4 | 100-150mg subcutaneous 2-3x weekly |
| Weeks 5+ | 150-250mg subcutaneous 2-3x weekly or monthly IV (250-750mg) |
Safety Profile
Side effects
- • Flushing and warmth
- • Nausea (especially IV)
- • Chest tightness during IV
- • Injection site soreness
Contraindications
- • Active cancer
- • Pregnancy
- • Breastfeeding
Frequently asked questions
NAD+ (Nicotinamide Adenine Dinucleotide) is most commonly researched for: Cellular energy production, DNA repair support, Anti-aging at cellular level, Improved mental clarity.
Ready to build a protocol with NAD+ (Nicotinamide Adenine Dinucleotide)?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.